Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects

American Journal of Gastroenterology

Volumn 94, Issue 7, 1999, Pages 1818-1822

  Anand, Bhupinderjit S ^a   Romero B s, Jim J ^b   Sanduja, Sudershan K ^c   Lichtenberger, Lenard M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Natural Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLSALICYLIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PROSTAGLANDIN SYNTHASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; FEMALE; GASTROSCOPY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH BIOPSY; STOMACH EROSION; STOMACH MUCOSA; STOMACH PROTECTION;

EID: 0033013798     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01211.x     Document Type: Article

References (25)

1. Barrier C.H., Hirshchowitz B.I. Controversies in the detection and management of nonsteroidal anti-inflammatory drug-induced side effects of the upper gastrointestinal tract. Arthritis Rheum. 32:1989;926-932.
2. Gabriel S.E., Jaakkimainen L., Bombardier C. Risk for serious gastrointestinal complications related to the use of nonsteroidal anti-inflammatory drugs. Ann Int Med. 115:1991;787-796.
3. Fries J.F., Miller S.R., Spitz P.W., et al. Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. Gastroenterology. 96:1989;647-655.
4. Kurata J.H., Abbey D.E. The effect of chronic aspirin use on duodenal and gastric ulcer hospitalization. J Clin Gastroenterol. 12:1990;260-266.
5. Weil J., Colin-Jones D., Langman M., et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J. 310:1995;827-830.
6. Cryer B., Luk G., Feldman M. Effects of low doses of aspirin on gastric, duodenal and rectal prostaglandins and mucosal injury. Gastroenterology. 108:1995;A77. (abstract).
7. Meade E.A., Smith W.L., Dewitt D.L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other nonsteroidal anti-inflammatory drugs. J Biol Chem. 268:1993;6610-6614.
8. Lipsky P.E., Isakson P.C. Outcome of specific COX-2 inhibition in rheumatoid arthritis. J Rheumatol. 24:(suppl 49):1997;9-14.
9. Bjarnason I., Macpherson A., Rotman H., et al. A randomized double-blind, cross-over study on the gastroduodenal tolerability of a highly specific cyclo-oxygenase-2 inhibitor, flosulide and naproxen. Scand J Gastroenterol. 32:1997;126-130.
10. Kiefer D.M. A century of pain relief. Today's Chemist at Work. December:1997;38-42.
11. Vane J.R., Flower R.J., Botting R.M. History of aspirin and its mechanism of action. Stroke. 21:(suppl IV):1990;12-23.
12. Wallace J.L. Nonsteroidal anti-inflammatory drugs and gastroenteropathy The second hundred years . Gastroenterology. 112:1997;1000-1016.
13. Lichtenberger L.M. The hydrophobic barrier properties of gastrointestinal mucus. Annu Rev Physiol. 57:1995;565-583.
14. Kao Y.C.J., Lichtenberger L.M. Phospholipid- and neutral-lipid organelles of the rat gastroduodenal mucus cells. Gastroenterology. 101:1991;7-21.
15. Goggin P.M., Marrero J.M., Spychal R.I., et al. Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection Effect of clearance and eradication . Gastroenterology. 103:1992;1486-1490.
16. 2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa. Gastroenterology. 88:1985;308-314.
17. Goddard P.M., Lichtenberger L.M. Does aspirin damage the canine gastric mucosa by reducing its surface hydrophobicity? Am J Physiol. 15:1987;G421-G430.
18. Lichtenberger L.M., Wang Z.-M., Romero J.J., et al. Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury . Nat Med. 1:1995;154-158.
19. Kurinets A., Lichtenberger L.M. Phosphatidylcholine-associated aspirin accelerates healing of gastric ulcers in rats. Dig Dis Sci. 43:1998;786-790.
20. Lichtenberger L.M., Ulloa C., Vanous A.L., et al. Zwitterionic phospholipids enhance aspirin's therapeutic activity, as demonstrated in rodent model systems. JPET. 277:1996;1221-1227.
21. Sanduja S.K., Xu X.M., Hsu S.M., et al. Differentiation-associated expression of prostaglandin H and thromboxane A synthases in monocytoid leukemia cells. Blood. 78:1991;3178-3185.
22. Sanduja S.K., Tsai A.L., Aleksic N.M., et al. Kinetics of prostacyclin synthesis in PGHS-1 overexpressed endothelial cells. Am J Physiol. 267:1994;C1459-C66.
23. Hawkey C.J. Non-steroidal anti-inflammatory drugs and peptic ulcers. Br Med J. 300:1990;278-284.
24. Schmassmann A. Mechanism of ulcer healing and effects of nonsteroidal anti-inflammatory drugs. Am J Med. 104:1998;43S-51S.
25. Wallace J.L., Reuter B., Cicala C., et al. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology. 107:1994;173-179.